Support Alert

Class 2 medicines recall: Ranitidine 75mg tablets

OTC Concepts Ltd, Relconchem Ltd and Noumed Life Sciences Ltd are recalling all unexpired batches of the products mentioned in the MHRA alert from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential. 

Medreich Plc are recalling specific batches of the products mentioned in the MHRA alert from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Further information including details of the affected products and batches, and advice for healthcare professionals and retail stores can be found on the MHRA website.
 

Loading...

Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.

RENEW YOUR MEMBERSHIP TODAY